Is the Adipose Tissue Vascular System a Therapeutic Target in the Era of Precision Medicine?
Medicinal Research Reviews · 29.10.2026
DOI: 10.1002/med.70121 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 29.10.2026. Verfasst von Daniela Rosendo-Silva und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, Coimbra, Portugal. Die Arbeit nennt 140 Literaturangaben. Gefördert von: FCT-Fundação para a Ciência e a Tecnologia, Horizon Europe - Health.
Abstract (Originalsprache)
Changes in adipose tissue function, morphology, and secretome during obesity impair endothelial cell function and lead to persistent hypoxia and unresolved inflammation, which will contribute to whole‐body endothelial dysfunction and chronic low‐grade inflammation. Indeed, visceral fat dysfunction is more associated with insulin resistance than body mass index. Understanding the molecular landscape of visceral adipose tissue is pivotal to better comprehending an individual's metabolic health and even predicting future health outcomes. Single‐cell studies are showing that the heterogeneity of the adipose depots relies not only on the diversity of cellular types, but also on the differential gene expression and secretome (even within the same cellular type). Adipose tissue cells respond in an orchestrated manner to adequate tissue plasticity to the current energetic needs, either by expanding or retracting. This response relies on coordinated regulation of adipocyte metabolism, angiogenesis, extracellular matrix remodeling, and short‐term inflammation and oxidative stress. In this review, we look closely at cell intercommunication in the fat depot and discuss the main events occurring in adipose tissue associated with the progressive tissue dysfunction that happens in obesity: adipocyte metabolism, angiogenesis, and extracellular matrix remodeling. Furthermore, we discuss the modulation of angiogenesis as a potential therapeutic target in obesity by gathering relevant recent research and collectively discuss the metabolic implications of inhibiting or promoting angiogenesis at different stages of the metabolic sequelae of obesity.
Autor:innen und Institutionen
- University of Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, Coimbra, Portugal.
- University of Coimbra, Center for Innovative Biomedicine and Biotechnology (CIBB), Coimbra, Portugal.
- Polytechnic University of Coimbra, Coimbra Health School (ESTeSC), Coimbra, Portugal.
- University of Coimbra, Institute for Interdisciplinary Research (IIIUC), Doctoral Programme in Experimental Biology and Biomedicine (PDBEB), Coimbra, Portugal.
ORCID-Profile: Daniela Rosendo-Silva, Diana Sousa, Carina C Magalhães, Paulo Matafome
Förderung
- FCT-Fundação para a Ciência e a Tecnologia
- Horizon Europe - Health
Zitieren
APA
Rosendo-Silva, D., Sousa, D., Magalhães, C. C., & Matafome, P. (2026). Is the Adipose Tissue Vascular System a Therapeutic Target in the Era of Precision Medicine?. Medicinal Research Reviews. https://doi.org/10.1002/med.70121
Vancouver
Rosendo-Silva D, Sousa D, Magalhães CC, Matafome P. Is the Adipose Tissue Vascular System a Therapeutic Target in the Era of Precision Medicine?. Medicinal Research Reviews. 2026. doi:10.1002/med.70121
BibTeX
@article{RosendoSilva2026,
author = {Rosendo-Silva, Daniela and Sousa, Diana and Magalhães, Carina C and Matafome, Paulo},
title = {Is the Adipose Tissue Vascular System a Therapeutic Target in the Era of Precision Medicine?},
journal = {Medicinal Research Reviews},
year = {2026},
doi = {10.1002/med.70121}
}
EUVIMED